Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Cardiac allograft vasculopathy laboratory findings
Introduction
Overview
Overview
Multiple biomarkers such as C-reactive protein, von Willebrand factor and NT-pro-BNP are used to predict all cause mortality in patients with CAV. Elevated levels of each of these biomarkers signify increased risk of developing CAV. Further research is warranted to help identify the role of biomarkers in diagnosing and predicting CAV[1].
References
References
- ↑ Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A; et al. (2007). “Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation”. Transplantation. 83 (10): 1308–15. doi:10.1097/01.tp.0000263338.39555.21. PMID 17519779.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2] Raviteja Guddeti, M.B.B.S. [3]